TY - JOUR
T1 - Body size, physical activity, and risk of triple-negative and estrogen receptor-positive breast cancer
AU - Phipps, Amanda I.
AU - Chlebowski, Rowan T.
AU - Prentice, Ross
AU - McTiernan, Anne
AU - Stefanick, Marcia L.
AU - Wactawski-Wende, Jean
AU - Kuller, Lewis H.
AU - Adams-Campbell, Lucile L.
AU - Lane, Dorothy
AU - Vitolins, Mara
AU - Kabat, Geoffrey C.
AU - Rohan, Thomas E.
AU - Li, Christopher I.
PY - 2011/3
Y1 - 2011/3
N2 - Background: Triple-negative breast cancer, characterized by a lack of hormone receptor and HER2 expression, is associated with a particularly poor prognosis. Focusing on potentially modifiable breast cancer risk factors, we examined the relationship between body size, physical activity, and triple-negative disease risk. Methods: Using data from 155,723 women enrolled in the Women's Health Initiative (median follow-up, 7.9 years), we assessed associations between baseline body mass index (BMI), BMI in earlier adulthood, waist and hip circumference, waist-hip ratio, recreational physical activity, and risk of triple-negative (n = 307) and estrogen receptor-positive (ER +, n = 2,610) breast cancers. Results: Women in the highest versus lowest BMI quartile had 1.35-fold (95% CI, 0.92-1.99) and 1.39-fold (95% CI, 1.22-1.58) increased risks of triple-negative and ER+ breast cancers, respectively. Waist and hip circumferences were positively associated with risk of ER+ breast cancer (Ptrend = 0.01 for both measures) but were not associated with triple-negative breast cancer. Compared with women who reported no recreational physical activity, women in the highest activity tertile had similarly lower risks of triple-negative and ER+ breast cancers (HR = 0.77; 95% CI, 0.51-1.13; and HR = 0.85; 95% CI, 0.74-0.98, respectively). Conclusions: Despite biological and clinical differences, triple-negative and ER+ breast cancers are similarly associated with BMI and recreational physical activity in postmenopausal women. The biological mechanisms underlying these similarities are uncertain and these modest associations require further investigation. Impact: If confirmed, these results suggest potential ways postmenopausal women might modify their risk of both ER+ and triple-negative breast cancers.
AB - Background: Triple-negative breast cancer, characterized by a lack of hormone receptor and HER2 expression, is associated with a particularly poor prognosis. Focusing on potentially modifiable breast cancer risk factors, we examined the relationship between body size, physical activity, and triple-negative disease risk. Methods: Using data from 155,723 women enrolled in the Women's Health Initiative (median follow-up, 7.9 years), we assessed associations between baseline body mass index (BMI), BMI in earlier adulthood, waist and hip circumference, waist-hip ratio, recreational physical activity, and risk of triple-negative (n = 307) and estrogen receptor-positive (ER +, n = 2,610) breast cancers. Results: Women in the highest versus lowest BMI quartile had 1.35-fold (95% CI, 0.92-1.99) and 1.39-fold (95% CI, 1.22-1.58) increased risks of triple-negative and ER+ breast cancers, respectively. Waist and hip circumferences were positively associated with risk of ER+ breast cancer (Ptrend = 0.01 for both measures) but were not associated with triple-negative breast cancer. Compared with women who reported no recreational physical activity, women in the highest activity tertile had similarly lower risks of triple-negative and ER+ breast cancers (HR = 0.77; 95% CI, 0.51-1.13; and HR = 0.85; 95% CI, 0.74-0.98, respectively). Conclusions: Despite biological and clinical differences, triple-negative and ER+ breast cancers are similarly associated with BMI and recreational physical activity in postmenopausal women. The biological mechanisms underlying these similarities are uncertain and these modest associations require further investigation. Impact: If confirmed, these results suggest potential ways postmenopausal women might modify their risk of both ER+ and triple-negative breast cancers.
UR - http://www.scopus.com/inward/record.url?scp=79955774979&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=79955774979&partnerID=8YFLogxK
U2 - 10.1158/1055-9965.EPI-10-0974
DO - 10.1158/1055-9965.EPI-10-0974
M3 - Article
C2 - 21364029
AN - SCOPUS:79955774979
SN - 1055-9965
VL - 20
SP - 454
EP - 463
JO - Cancer Epidemiology Biomarkers and Prevention
JF - Cancer Epidemiology Biomarkers and Prevention
IS - 3
ER -